TwitterLinkedInYouTubeslideshareflickrIFPMA - Global Health Matters - BlogRSS
IFPMA Home

International Federation of Pharmaceutical Manufacturers & Associations



In this video, Andrew Jenner, IFPMA’s Executive Director, Corporate Strategy & Legal Affairs, gives the pharmaceutical industry perspective on innovation. Despite the growing scientific, intellectual property and regulatory challenges of the past decades, over 340 new drugs have been introduced since 2002 to treat different chronic and non-chronic diseases. This can be considered as a big success story. Watch the video to find out why.

Jenner’s take is essentially based on the value of innovation from two dimensions: clinical and economic. These two dimensions are well demonstrated in two recently launched studies in 2014: the first, carried out by Charles River Associates, Assessing the value of biopharmaceutical innovation in key therapy areas in middle-income countries. The latter is evidenced by WifOR’s “First steps towards measuring the economic footprint of the industry”. To find out more about our organization: www.ifpma.org

Events
Resources

UPDATED! Developing World Health Partnerships Directory

The research-based pharmaceutical industry engages in a wide range of public-private partnerships...

IFPMA Code of Practice

Expanded IFPMA Code of Practice updates ethical and professional standards for interacting with...

Interview Series

The IFPMA Interview Series is a video library of interviews with people from different walks of...